Robert J. Evans

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Journal: Investigational new drugs
Published: March 03, 2026

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Journal: British journal of cancer
Published: December 19, 2025

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms.

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms.

Journal: British journal of cancer
Published: December 15, 2025

Feasibility & clinical utility of Comprehensive Geriatric Assessment (CGA) and interventions in older adults with prostate cancer on Androgen Deprivation Therapy (ADT); a retrospective service evaluation.

Feasibility & clinical utility of Comprehensive Geriatric Assessment (CGA) and interventions in older adults with prostate cancer on Androgen Deprivation Therapy (ADT); a retrospective service evaluation.

Journal: BMC geriatrics
Published: July 14, 2025

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Journal: British journal of cancer
Published: April 10, 2025

Feasibility and Outcomes of Craniospinal Irradiation and Concurrent Daily Carboplatin in Children and Adults With High-risk Central Nervous System Tumours.

Feasibility and Outcomes of Craniospinal Irradiation and Concurrent Daily Carboplatin in Children and Adults With High-risk Central Nervous System Tumours.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 18, 2024

Intestinal microbiota profiles of captive-bred cynomolgus macaques reveal influence of biogeography and age.

Intestinal microbiota profiles of captive-bred cynomolgus macaques reveal influence of biogeography and age.

Journal: Animal microbiome
Published: December 03, 2024

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 22, 2023

Sustainability in healthcare: patient and public perspectives.

Sustainability in healthcare: patient and public perspectives.

Journal: Anaesthesia
Published: September 11, 2023

Blood vessel occlusion by Cryptococcus neoformans is a mechanism for haemorrhagic dissemination of infection.

Blood vessel occlusion by Cryptococcus neoformans is a mechanism for haemorrhagic dissemination of infection.

Journal: PLoS pathogens
Published: December 17, 2021

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

Journal: Cell death & disease
Published: November 11, 2021

HRMAn 2.0: Next-generation artificial intelligence-driven analysis for broad host-pathogen interactions.

HRMAn 2.0: Next-generation artificial intelligence-driven analysis for broad host-pathogen interactions.

Journal: Cellular microbiology
Published: March 06, 2021
Showing 1-12 of 73

Last Updated: 09/26/2026